For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Oxford

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.

Type
D - Journal article
Title of journal
J Clin Oncol
Article number
-
Volume number
29
Issue number
15
First page of article
1997
ISSN of journal
1527-7755
Year of publication
2011
Number of additional authors
15
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
D - (CAN) Cancer
Citation count
49
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-